Evidence map›Paper›PMID 29293983›Full record

SynthesisEuropean heart journal. Cardiovascular Imaging2018

Quantitative myocardial perfusion evaluation with positron emission tomography and the risk of cardiovascular events in patients with coronary artery disease: a systematic review of prognostic studies.

Luis Eduardo Juárez-Orozco, Rene A Tio, Erick Alexanderson, Marc Dweck, Rozemarijn Vliegenthart, Mostafa El Moumni, Niek Prakken, Ivan Gonzalez-Godinez, Riemer H J A Slart

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in European heart journal. Cardiovascular Imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Natural History of Myocardial αJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Trial
  2. Diagnosis of multivessel coronary artery disease usingJapanese journal of radiology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Significance of myocardial flow reserve after revascularization.European heart journal. Cardiovascular Imaging · 2023
    Article
  9. Article
  10. Article
  11. More evidence for prognostic value of quantification of myocardial perfusion.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  12. Long-Term Prognostic Value ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  13. Incremental prognostic value of positron emission tomography derived left ventricular mass.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Global and segmental absolute stress myocardial blood flow in prediction of cardiac events: [European journal of nuclear medicine and molecular imaging · 2021
    Article
  19. Review
  20. Ventricular synchrony is not significantly determined by absolute myocardial perfusion in patients with chronic heart failure: AJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Luis Eduardo Juárez-OrozcoDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Internal Postcode: EB50, 9700 RB, Groningen, The Netherlands.
Rene A TioDepartment of Cardiology, Catharina Hospital, Michelangelolaan 2, EJ, Eindhoven, The Netherlands.
Erick AlexandersonDepartment of Nuclear Cardiology, Instituto Nacional de Cardiología "Ignacio Chávez", Juan Badiano 1, Belisario Domínguez Secc 16, Tlalpan, CDMX, Mexico.
Marc DweckBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Little France Crescent, Edinburgh, UK.
Rozemarijn VliegenthartDepartment of Radiology, University Medical Center Groningen, Center for Medical Imaging, University of Groningen, Hanzeplein 1 UMCG, RB, Groningen, The Netherlands.
Mostafa El MoumniDepartment of Traumatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 UMCG, 9700RB, Groningen, The Netherlands.
Niek PrakkenDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Internal Postcode: EB50, 9700 RB, Groningen, The Netherlands.
Ivan Gonzalez-GodinezDepartment of Internal Medicine, Dalinde Medical Center, Tuxpan 25, Colonia Roma, C.P. CDMX, Mexico.
Riemer H J A SlartDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Internal Postcode: EB50, 9700 RB, Groningen, The Netherlands.

Funding

British Heart Foundation FS/14/78/31020
6 · The paper itself

Abstract

Aims: To evaluate the prognostic value of quantitative myocardial perfusion imaging with positron emission tomography (PET) for adverse cardiovascular outcomes in patients with known or suspected coronary artery disease (CAD). Methods and results: A search in MEDLINE and Embase was conducted for studies that evaluated (i) myocardial perfusion in absolute terms with PET, (ii) prognostic value for the development of major adverse cardiovascular events (MACE), cardiac death, and/or all-cause mortality, and (iii) patients with known or suspected CAD. Studies were divided according to the radiotracer utilized and their included population (patients with and without previous infarction). Comprehensive description and a selected instance of pooling were performed. Eight studies (n = 6804) were analysed and documented clear variability in population, quantitative PET variables operationalization [stress myocardial blood flow (sMBF) and flow reserve (MFR)], statistical covariate structure, follow-up, and radiotracer utilized. MFR was independently associated with MACE in eight studies [range of adjusted hazard ratios (HRs): 1.19-2.93]. The pooling instance demonstrated that MFR significantly associates with the development of MACEs (HR: 1.92 [1.29, 2.84]; P = 0.001). sMBF was only associated with MACE in two studies that evaluated it, and only one study documented sMBF as a better predictor than MFR. Conclusion: This systematic review demonstrates the prognostic value of quantitative myocardial perfusion evaluated with PET, in the form of MFR and sMBF, for the development of major adverse cardiovascular outcomes in populations with known or suspected CAD. In the qualitative comparison, MFR seems to outperform sMBF as an independent prognostic factor. Evidence is still lacking for assessing quantitative PET for the occurrence of cardiac death and all-cause mortality. There is clear heterogeneity in predictor operationalization and study performances.

Indexed as

Myocardial Perfusion ImagingPositron-Emission TomographyCoronary Artery DiseaseHumansPrognosis

Identifiers

PMID29293983
PMCPMC6148746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.